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ataxia and tremor in people  
with multiple sclerosis (MS)
Ataxia and tremor are common yet 
difficult symptoms to manage in 
people with MS ― often requiring the 
involvement of a multidisciplinary team. 
Early intervention is important in order 
to address both the functional and 
psychological issues associated with 
these symptoms.
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1.0 Definitions
2.0 Incidence and impact
3.0 Pathophysiology and clinical characteristics
Ataxia
Ataxia is a term used to describe a number of 
abnormal movements that may occur during the 
execution of voluntary movements. They include, but 
are not limited to, incoordination, delay in movement, 
dysmetria (inaccuracy in achieving a target), 
dysdiadochokinesia (inability to perform movements 
of constant force and rhythm), and tremor.1 Ataxia can 
be the result of damage to the cerebellum (cerebellar 
ataxia) or the posterior columns of the spinal cord 
(sensory ataxia) or dysfunction of the vestibular 
system (vestibular ataxia).
Tremor
Tremor is defined as a rhythmic, involuntary, oscillating 
movement of a body part. There are two main 
classifications of tremor ― resting tremor and action 
tremor. Resting tremor is present in a body part that 
is completely supported against gravity and is not 
voluntarily activated. Action tremor is produced during 
body part movement.5 Action tremor may be further sub-
classified into intention, postural, kinetic, and isometric 
tremor, of which intention and postural are the two most 
prevalent forms (refer to section 3.1 ‘Pathophysiology 
and clinical characteristics of tremor’).
3.1 Ataxia
There are three forms of ataxia that may occur in 
isolation, or in combination, in people with MS. These 
are sensory, cerebellar, and vestibular ataxia.6
Sensory ataxia is a result of damage to the sensory 
pathways responsible for transmitting proprioceptive 
information.11 Sensory examination usually reveals the 
loss of position and vibration sense, with a significant 
worsening of symptoms when the eyes are closed.3 
When comparing movement tests at constant speed, 
performance is significantly worse when the eyes are 
closed. This is due to loss of proprioception (sensation 
of joint and body part position).
Vestibular ataxia may result from damage to the 
vestibulocochlear nerve (VIII cranial nerve) or its central 
connections, which are located in the brainstem and 
vestibular nuclei. More commonly, vestibular ataxia 
results from cerebellar damage. The cerebellum is the 
major port of integration for all the aforementioned 
neural connections. Symptoms include, but are not 
limited to, vertigo (dizziness), nausea, loss of balance 
Studies report that up to 85% of people with MS may experience ataxia and/or tremor at some point in time. 
Ataxia and tremor are often accompanied by other symptoms such as weakness, spasticity, and reduced sensory 
or visual input.6 It is not surprising that ataxia is reported to affect function in up to 32% of people with MS.7 
Greater levels of ataxia in people with MS appear to correlate with higher levels of respiratory symptoms,8,9 and 
severe tremor correlates with the presence of dysarthria.10
and nystagmus (rapid rhythmic and repetitious 
involuntary eye movements).11
Cerebellar ataxia is a result of damage to the 
cerebellum, or parts of the brain that connect to the 
cerebellum. This includes cerebellar peduncles and the 
pons or red nucleus. The symptoms of cerebellar  
ataxia are dependent on the location of the damage 
and may include upper limb incoordination, 
disturbance of posture and walking (ataxic gait), 
dysmetria, dysdiadochokinesia, nystagmus or speech 
(dysarthria).1 Cerebellar ataxia is often significantly 
worse when comparing movement tests at a faster 
speed. Closing the eyes may only minimally worsen test 
movement execution. 
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4.0 Assessment
The assessment of ataxia  
and tremor should be
integrated into a functional 
analysis assessment using
general measures of function...
as well as specific measures of 
ataxia and tremor.
3.2 Tremor
Tremor is often experienced as rhythmic shaking 
movements that can be small or large in amplitude. 
Tremor in people with MS can affect the head, neck, 
vocal cords, trunk or limbs, and is predominantly 
action tremor.10 A classification system for tremor was 
published by deuschl et al. in 1998 and may be a 
useful reference for the practicing clinician.5
The upper limbs are the most commonly affected body 
parts for tremor in people with MS.10,13
The pathophysiology of tremor in MS is complex  
and not well understood due to the multi-focal  
damage typical of MS. however, the predominance  
of action tremors suggests that the cerebellum  
and its connections are the most likely source of 
tremor production.12 
The assessment of ataxia and tremor should be 
integrated into a functional analysis assessment  
using general measures of function, (such as the 
10-metre walk test, timed up-and-go test, 9-hole peg 
test and the spiral test) as well as specific measures  
of ataxia and tremor.
Three of the specific tools devised to measure 
ataxia or tremor in people with MS include:
International Cooperative Ataxia rating Scale 
(ICArS): 14 This scale utilises traditionally known 
tests such as the finger-to-nose, heel-to-shin, walking, 
drawing, speech and oculomotor movements tests with 
qualitative analysis. ICARS has been shown to be a 
reliable and repeatable measure of ataxia.15
Fahn Tremor rating Scale (FTrS): 16 The FTRS 
assesses intention tremor in the terminal period of 
the finger-to-nose test. A modified version, without the 
functional disability rating scale, has been assessed for 
use with people with MS. It was found to be a reliable 
and potentially useful tool for assessing movement 
disorders in people with MS.17
0–10 tremor severity scale: The scale was devised by 
Bain et al. in 1993. It has been shown to be a valid and 
reliable measurement tool for tremor severity in people 
with MS.18
Intention tremor – tremor present during target-
directed movement. Tremor amplitude increases 
during visually guided movement towards  
a target.
Postural tremor – tremor present while 
voluntarily maintaining a position against gravity.
The two most prevalent forms  
of action tremor in MS are: 12
The cerebellum has a highly integrative role  
for many of the body systems including vision, 
sensation, temperature, limb position and movement. 
The results of any assessment must be interpreted in 
light of these systems due to their potential to influence 
the measures.
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5.0 Management 
Although ataxia and tremor are very common,  
few studies have investigated the efficacy of 
management of these symptoms, which may still 
be perceived as nonresponsive to medical and 
rehabilitative therapies.19 The National Institute for 
Health and Clinical Excellence in the United Kingdom 
(www.nice.org.uk) has developed a set of guidelines 
known as the ‘NICE’ guidelines for the management of 
MS symptoms. These guidelines, which are based on a 
critical review of available evidence, recommend that:
n Any person with MS who experiences a limitation 
of activities due to tremor should be assessed by 
a specialist rehabilitation team for appropriate 
pharmacological management, treatment 
techniques, and equipment. 
n If problems remain severe and intractable, the 
person should be assessed by a neurosurgical team 
from a specialist centre. Their suitability for surgery 
to reduce ataxia can be addressed. 
Randomised controlled studies that demonstrate 
changes in locomotion function through exercise 
interventions for people with cerebellar dysfunction 
(with or without MS) are limited. A Cochrane 
review of ataxia in MS found limited support 
for pharmacotherapies, neurosurgery or neuro 
rehabilitation for the improvement of ataxia, tremor 
or function.19 Two studies investigating physiotherapy 
failed to exclude individuals with other deficits, 
consequently compromising the integrity of the 
research. However, strong evidence from animal 
studies show recovery from cerebellar dysfunction 
through adaptation and compensation of neighbouring 
areas of the cerebellum. 
Success of rehabilitation for people with MS is 
dependent on a number of factors. Cerebellar 
dysfunction has been highlighted as one such inhibiting 
factor.20 People with MS with cerebellar damage seem 
to experience greater difficulty improving movement 
execution than healthy individuals. More severely 
affected individuals demonstrate no learning of 
automated movements.4 The combination of cerebellar 
and other symptoms, such as weakness, spasticity, 
and/or visual loss, may further worsen rehabilitation 
outcomes, as is experienced by people with stroke.21 
Conversely, the management of these other  
symptoms may assist in reducing the overall impact  
of ataxia and tremor on physical and social abilities. 
The decomposition and slowness of movement may  
be difficult to improve as these strategies are likely  
to be employed by people with ataxia in order to 
optimise function.
5.1 Physiotherapy
Few studies have looked at the effectiveness of 
different physiotherapy interventions on reducing ataxia 
and tremor, as well as improving functional activities. 
To date, the scientific evidence used to support clinical 
practice in physiotherapy is of low levels (levels 2a–4). 
In addition, translating research success into practice 
is hampered by a lack of appropriate detail regarding 
these therapeutic interventions.
Physiotherapy interventions used to manage 
ataxia include: 
n Exercises that promote dynamic and static  
stability of the trunk and limbs. This is achieved  
by practising tasks that rely on adapting or 
developing strategies to cope with increasingly 
demanding conditions. For example, tandem 
walking and walking on different surfaces, walking 
with the eyes open and closed, and starting 
movements slowly with gradual increase in 
movement complexity, postural stability, or speed 
(evidence level 2a–4).23–27
n The use of patterning and proprioceptive 
neuromuscular facilitation.27 Use mat activities 
with proprioceptive neuromuscular facilitation 
techniques, combined with balance training, to help  
enhance postural stability and balance reactions. 
Introduce crawling, kneeling, half-kneeling 
positions, as well as co-contraction of agonist and 
antagonist muscles in static and dynamic balance 
training. These techniques employ the underlying 
clinical assumption that repetition and practise  
of patterned and facilitated movements can  
improve coordination.
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n Current evidence suggests that the use of weights 
to manage ataxia, or reduce ataxia and improve 
function, is of no benefit. In fact the use of weights 
is more beneficial in reducing tremor and improving 
functions (see below). one of the reasons for 
misinterpretation around the clinical use of weights 
is that the majority of studies on ataxia and tremor 
simultaneously investigated the effect of weights on 
intention tremor and functional tasks, or with tests 
traditionally used to quantify ataxia.28,29
Each of these aforementioned strategies requires 
extensive practise, especially when the aim is to 
enhance cortical re-organisation for skill acquisition 
and re-learning.
Physiotherapy interventions used to manage 
tremor include:
n weights – The use of weights to manage  
tremor is currently demonstrated to have  
positive outcomes with improvement of intention 
tremor frequencies;29–31 however, this benefit has 
not been found among other types of tremor.31  
The mechanism by which the improvement of 
tremor occurs appears to be mechanical, with 
increased muscle activity dampening tremor 
amplitude.29 Caution is required when using  
weights to dampen tremor since the application  
of too much weight may worsen tremor frequencies 
(evidence level 4).30,31
n Full limb cooling – This technique is advocated to 
produce a temporary reduction in tremor, which 
can last for up to 30 minutes (evidence level 4).32 
Undertaking full limb cooling without appropriate 
training is not recommended.
overall, there is no strong evidence to support the 
clinical use of the aforementioned therapies for  
ataxia and tremor. However, physiotherapists should 
consider the value of these therapies for the temporary 
relief of ataxia and tremor symptoms. They may allow  
a client to perform functions that are otherwise difficult 
or impossible. 
Compensatory strategies may be employed when 
physiotherapy techniques fail to improve ataxia and 
tremor symptoms or general function. Compensatory 
strategies aim to reduce joint movement complexity, 
reduce movement speed and/or encourage single  
joint movements. occupational therapy expertise 
plays a key role in this form of ataxia and tremor 
management and may involve splinting, equipment 
and/or adaptive supports.3 
In Australia, geography can limit access to health 
services for people with MS. However if local 
physiotherapists are educated about MS, people with 
MS are better serviced and can access support from 
specialists as required.
5.2 Pharmacotherapy 
To date, medications used to treat ataxia have shown 
limited efficacy but are associated with extensive side 
effects. There are currently no drugs available that can 
completely subdue tremor.6 Several drugs are being 
trialled for the reduction of tremor such as propranolol, 
clonazepam, primidone, isoniazid, buspirone, 
ondansetron. The hepatotoxic effects of some of these 
drugs often prevents their use at optimal doses and 
limits their long-term use.27 
In recent years anecdotal evidence has suggested that 
cannabis and its major component, cannabinoid, may 
have beneficial effects on MS-related symptoms such 
as pain, tremor, and spasticity. However, double-blind, 
randomised, controlled trials have found no beneficial 
application of cannabinoid in the management of 
tremor or ataxia. In addition the use of this drug can 
have serious side effects.33–36 
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5.3 Surgical intervention
Surgical intervention for the management of 
tremor is only considered when pharmacotherapy 
has been unsuccessful and the client’s functional 
status is severely impaired by the tremor. Surgical 
interventions used to alleviate MS-related tremor 
include thalamotomy and thalamic stimulation (deep 
brain stimulation).6,37 The long-term results of deep 
brain stimulation are theoretically more promising than 
thalamotomy. Several case series have demonstrated 
a significant reduction in tremor following thalamic 
deep brain stimulation in people with MS. However at 
long-term follow-up tremor had returned in all subjects, 
albeit to a lesser extent than prior to surgery.38 Deep 
brain stimulation carries a significant risk of transient 
and permanent complications.39 Investigations of 
thalamotomy have been limited to case study reports 
only. To date, few investigations have been undertaken 
in the area of surgical management of ataxia.
n The best therapy outcomes are achieved in 
individuals with minimal ataxic symptoms who 
commence intervention soon after symptom onset. 
n Other symptoms associated with ataxia and tremor 
(e.g., weakness, spasticity, dizziness or fatigue) 
must be addressed to minimise their influence  
on function.
n Physiotherapy strategies that involve repetitive and 
progressively more challenging functional training, 
or repetitive neuromuscular facilitation techniques, 
may be useful in the management of ataxia in 
people with MS.
n Weights may be useful in the management of 
tremor to achieve improved function.
n Full limb cooling may be useful to achieve a 
temporary reduction of tremor and a corresponding 
temporary improvement in function or practise  
of tasks.
n Training compensation strategies may be the  
most effective intervention in people with severe 
ataxia or tremor.
n Individuals with severe ataxia should be monitored 
and treated as required for respiratory impairments. 
n People with MS should be considered for  
referral to their doctor or specialist to discuss 
pharmacological or surgical interventions that  
support their overall therapy goals.
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Disclaimer
this handout is intended to provide information to 
support current best practice for the management 
and treatment of physical impairments in people with 
ms. while the information is available to all health 
professionals, there are details that are most relevant to 
physiotherapists, exercise physiologists, and people who 
are qualified to provide exercise opportunities for people 
with ms. ms Australia has made every effort to ensure 
that the information in this publication is correct. msA 
does not accept legal responsibility or liability for any 
errors or omissions, or for any physical or financial loss 
incurred whilst participating in the exercises or activities 
outlined in the MS Practice handouts. Be sure to seek 
advice from the sources listed.
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